Perioperative Cardiac Risk Stratification and Modification in Abdominal Aortic Aneurysm Repair

Abstract Cardiovascular complications are important causes of morbidity and mortality following vascular surgery. Adequate preoperative risk assessment and perioperative management may modify postoperative mortality and morbidity and improve long-term prognosis. The objective of this review is to examine the present day knowledge regarding the preoperative evaluation and perioperative management of patients undergoing noncardiac surgery, focusing specifically on abdominal aortic aneurysm (AAA) repair. Clinical markers combined with ECG and surgical risk assessment can effectively divide patients in a truly low-risk, intermediate and high-risk population. Low-risk patients can probably be operated on without additional cardiac testing. Notably, due to the surgical risk, AAA patients are never low-risk patients. Intermediate-risk and high-risk patients are referred for cardiac testing to exclude extensive stress induced myocardial ischemia, as beta-blockers provide insufficient myocardial protection in this case and preoperative coronary revascularization might be considered. Whether patients at intermediate risk without ischemic heart disease should be treated with statins and/or beta-blockers is still controversial. In high-risk patients, it is strongly advised to administer beta-blockers with heart rate determined dose adjustment, while the effects of preoperative revascularization remain subject to debate.

[1]  Jeroen J. Bax,et al.  Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery. , 2006, The American journal of cardiology.

[2]  Jeroen J. Bax,et al.  Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. , 2005, The American journal of medicine.

[3]  H. Yeh,et al.  Preoperative plasma N‐terminal pro‐brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non‐cardiac surgery , 2005, The British journal of surgery.

[4]  P. Lindenauer,et al.  Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.

[5]  Gordon H Guyatt,et al.  How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.

[6]  Roger M. Greenhalgh,et al.  Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. , 2005, Lancet.

[7]  B. Caramelli,et al.  Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. , 2005, Journal of vascular surgery.

[8]  J. Ioannidis,et al.  Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. , 2005, Journal of the American College of Cardiology.

[9]  Thomas E. Moritz,et al.  Coronary-artery revascularization before elective major vascular surgery. , 2004, The New England journal of medicine.

[10]  Jeroen J. Bax,et al.  Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. , 2004, American heart journal.

[11]  M. Sabatine,et al.  Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. , 2004, Journal of the American College of Cardiology.

[12]  P. Lindenauer,et al.  Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery , 2004, JAMA.

[13]  Jeroen J. Bax,et al.  Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. , 2004, The American journal of medicine.

[14]  R. Stevens,et al.  Pharmacologic Myocardial Protection in Patients Undergoing Noncardiac Surgery: A Quantitative Systematic Review , 2003, Anesthesia and analgesia.

[15]  Jeroen J. Bax,et al.  Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery , 2003, Circulation.

[16]  E. Antman,et al.  ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati , 2002, Journal of the American College of Cardiology.

[17]  L. Goldman,et al.  beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.

[18]  I. Kamae,et al.  Efficacy of Clonidine for Prevention of Perioperative Myocardial Ischemia: A Critical Appraisal and Meta-analysis of the Literature , 2002, Anesthesiology.

[19]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[20]  L. Goldman,et al.  Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). , 1999, Anesthesiology.

[21]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[22]  Farris K. Timimi,et al.  The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. , 1999, Anesthesia and analgesia.

[23]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[24]  Allan S. Detsky,et al.  Predicting cardiac complications in patients undergoing non-cardiac surgery , 1986, Journal of General Internal Medicine.

[25]  N. Hertzer,et al.  Coronary Artery Disease in Peripheral Vascular Patients: A Classification of 1000 Coronary Angiograms and Results of Surgical Management , 1984, Annals of surgery.

[26]  L Goldman,et al.  Multifactorial index of cardiac risk in noncardiac surgical procedures. , 1977, The New England journal of medicine.

[27]  M. Sydes,et al.  Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. , 2005, Journal of vascular surgery.

[28]  Jeroen J. Bax,et al.  Comparison between serum creatinine and creatinine clearance for the prediction of postoperative mortality in patients undergoing major vascular surgery. , 2003, Clinical nephrology.